DIFFUSE MIDLINE GLIOMA
Clinical trials for DIFFUSE MIDLINE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE MIDLINE GLIOMA trials appear
Sign up with your email to follow new studies for DIFFUSE MIDLINE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vitamin c and iron combo takes on brain cancer in early trial
Disease control OngoingThis early-phase trial tests whether adding high-dose vitamin C and an iron supplement (ferumoxytol) to standard radiation and chemotherapy can help adults with newly diagnosed glioblastoma, an aggressive brain tumor. The study includes 17 participants and focuses on finding a sa…
Matched conditions: DIFFUSE MIDLINE GLIOMA
Phase: PHASE1 • Sponsor: Bryan Allen • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New combo therapy aims to fight aggressive brain tumors in kids
Disease control TerminatedThis study tests a combination of a vaccine targeting the CMV virus (PEP-CMV) and an immunotherapy drug (nivolumab) in children and young adults with certain aggressive brain tumors, including diffuse midline glioma and medulloblastoma. The goal is to see if this approach is safe…
Matched conditions: DIFFUSE MIDLINE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Engineered immune cells delivered directly to the brain show promise for kids with deadly tumors
Disease control OngoingThis early-stage trial tests a new treatment for children and young adults up to age 21 with certain brain tumors that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack a pro…
Matched conditions: DIFFUSE MIDLINE GLIOMA
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New brain cancer drug shows promise in early trial
Disease control TerminatedThis early-phase study tests whether adding a drug called S-Gboxin to standard treatment can help people with glioblastoma, a fast-growing brain cancer. The drug works by cutting off the energy supply to cancer cells. Ten patients with recurrent or progressive disease will receiv…
Matched conditions: DIFFUSE MIDLINE GLIOMA
Phase: PHASE1 • Sponsor: Petrov, Andrey • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Engineered immune cells injected directly into the brain take on childhood tumors
Disease control OngoingThis early-stage trial tests a new treatment called SC-CAR4BRAIN for children and young adults with certain aggressive brain tumors, including DIPG and DMG. The treatment involves taking a patient's own immune T cells, engineering them in a lab to recognize and attack tumor cells…
Matched conditions: DIFFUSE MIDLINE GLIOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can a pill get into brain tumors? tiny study aims to find out
Knowledge-focused OngoingThis early study tests whether the drug abemaciclib can be measured inside brain tumors after being taken by mouth. One person aged 18–39 with a recurrent high-grade glioma or diffuse midline glioma will take the drug for 4.5 days before surgery. During surgery, a small tube is p…
Matched conditions: DIFFUSE MIDLINE GLIOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC